Trial Profile
A phase II dose-ranging study of SYR-472
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Trelagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda
- 25 May 2016 New trial record